JW Shinyak Corporation (KOSDAQ:067290)
South Korea · Delayed Price · Currency is KRW 1,590.00
+7.00 (0.44%)
At close: Aug 6, 2025, 3:30 PM KST
JW Shinyak Company Description
JW Shinyak Corporation engages in the research, development, production, and sale of medicines and medical supplies in South Korea.
It offers pharmaceutical products in the areas of dermatology, urology, pediatrics, otolaryngology, etc.; and cardiovascular, gastrointestinal, urinary, NSAIDs, antibiotics, anti-fungal, anti-viral, respiratory, antihistamines, steroid hormone, anti-obesity, and other products, as well as eye drops, and antitussives and expectorants.
The company also develops prostate cancer treatment, liver cancer treatment, rheumatoid arthritis treatment, etc. using immune cells.
JW Shinyak Corporation was founded in 1981 and is headquartered in Gwacheon-si, South Korea.
JW Shinyak Corporation
| Country | South Korea |
| Founded | 1981 |
| Industry | Orthopedic, Prosthetic, and Surgical Appliances and Supplies |
| Employees | 197 |
| CEO | Yong-Kwan Kim |
Contact Details
Address: JW Tower Gwacheon-si, 13840 South Korea | |
| Phone | 82 2 2109 3300 |
| Website | jw-shinyak.co.kr |
Stock Details
| Ticker Symbol | 067290 |
| Exchange | KOSDAQ |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | KRW |
| SIC Code | 3842 |
Key Executives
| Name | Position |
|---|---|
| Yong-Kwan Kim | Chief Executive Officer |